Review





Similar Products

94
Santa Cruz Biotechnology socs3
Socs3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/SOCS-3+Antibody/pm42971141-52-25-52
Average 94 stars, based on 1 article reviews
socs3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology rabbit anti socs3
Rabbit Anti Socs3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/SOCS3+Rabbit+pAb/pm42907736-131-42-45
Average 94 stars, based on 1 article reviews
rabbit anti socs3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Proteintech socs3
IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, STAT4, p‑STAT3, STAT3, SOCS1, <t>SOCS3,</t> and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Socs3, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/SOCS3+Antibody/pmc13673060-199-57-58
Average 95 stars, based on 1 article reviews
socs3 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
ABclonal Biotechnology socs3
IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, STAT4, p‑STAT3, STAT3, SOCS1, <t>SOCS3,</t> and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Socs3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/SOCS3+Rabbit+pAb/10__1186_slash_s12951___026___05112___8-357-36-37
Average 94 stars, based on 1 article reviews
socs3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Elabscience Biotechnology rabbit antisocs3
IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, STAT4, p‑STAT3, STAT3, SOCS1, <t>SOCS3,</t> and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Rabbit Antisocs3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/SOCS3+Polyclonal+Antibody/10__1016_slash_j__cej__2026__180875-169-49-53
Average 96 stars, based on 1 article reviews
rabbit antisocs3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
ABclonal Biotechnology socs1
Focal rTSMS significantly inhibits CCI-induced neuroinflammation and upregulates SOCS3 in the spinal cord in vivo . (A) Representative immunofluorescence images showing the inhibitory effects of focal rTSMS on CCI-induced activation of microglia and astrocytes in the dorsal horn ( n = 3). Dashed box indicates the region of interest in the dorsal horn of the spinal cord. Scale bars: 100 μm. (B) Representative image of western blotting. (C, D) Re-administration of rTSMS significantly inhibited the CCI-induced upregulation of Iba-1 and GFAP ( n = 5). (E–G) Focal rTSMS significantly inhibited CCI-induced upregulation of IL-1β, IL-6, and TNF-α in the spinal cord ( n = 5). (H, I) Focal rTSMS significantly inhibited the CCI-induced increase in the protein levels of p-p38 and p-STAT3 in the spinal cord ( n = 5). (J) Focal rTSMS significantly upregulated SOCS3 in the spinal cord ( n = 5). (K) Focal rTSMS could not upregulate <t>SOCS1</t> in the spinal cord ( n = 5). Data are expressed as mean ± SD. # P < 0.05, ### P < 0.001, #### P < 0.0001, vs. Sham group; * P < 0.05, ** P < 0.01, *** P < 0.001, vs . CCI group (one‐way analysis of variance followed by Tukey’s multiple comparisons tests). CCI: Chronic constrictive injury; GFAP: glial fibrillary acidic protein; Iba-1: ionized calcium binding adaptor molecule-1; IL: interleukin; rTSMS: repetitive trans-spinal magnetic stimulation; SOCS: suppressor of cytokine signaling; STAT3: transducer and activator of transcription 3; TNF-α: tumor necrosis factor-alpha.
Socs1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/SOCS3+Rabbit+pAb/pmc13378957-82-23-26
Average 94 stars, based on 1 article reviews
socs1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Servicebio Inc socs3
Focal rTSMS significantly inhibits CCI-induced neuroinflammation and upregulates SOCS3 in the spinal cord in vivo . (A) Representative immunofluorescence images showing the inhibitory effects of focal rTSMS on CCI-induced activation of microglia and astrocytes in the dorsal horn ( n = 3). Dashed box indicates the region of interest in the dorsal horn of the spinal cord. Scale bars: 100 μm. (B) Representative image of western blotting. (C, D) Re-administration of rTSMS significantly inhibited the CCI-induced upregulation of Iba-1 and GFAP ( n = 5). (E–G) Focal rTSMS significantly inhibited CCI-induced upregulation of IL-1β, IL-6, and TNF-α in the spinal cord ( n = 5). (H, I) Focal rTSMS significantly inhibited the CCI-induced increase in the protein levels of p-p38 and p-STAT3 in the spinal cord ( n = 5). (J) Focal rTSMS significantly upregulated SOCS3 in the spinal cord ( n = 5). (K) Focal rTSMS could not upregulate <t>SOCS1</t> in the spinal cord ( n = 5). Data are expressed as mean ± SD. # P < 0.05, ### P < 0.001, #### P < 0.0001, vs. Sham group; * P < 0.05, ** P < 0.01, *** P < 0.001, vs . CCI group (one‐way analysis of variance followed by Tukey’s multiple comparisons tests). CCI: Chronic constrictive injury; GFAP: glial fibrillary acidic protein; Iba-1: ionized calcium binding adaptor molecule-1; IL: interleukin; rTSMS: repetitive trans-spinal magnetic stimulation; SOCS: suppressor of cytokine signaling; STAT3: transducer and activator of transcription 3; TNF-α: tumor necrosis factor-alpha.
Socs3, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/anti+socs3/pm42129631-82-8-13
Average 86 stars, based on 1 article reviews
socs3 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Jackson Laboratory socs3 mouse
Focal rTSMS significantly inhibits CCI-induced neuroinflammation and upregulates SOCS3 in the spinal cord in vivo . (A) Representative immunofluorescence images showing the inhibitory effects of focal rTSMS on CCI-induced activation of microglia and astrocytes in the dorsal horn ( n = 3). Dashed box indicates the region of interest in the dorsal horn of the spinal cord. Scale bars: 100 μm. (B) Representative image of western blotting. (C, D) Re-administration of rTSMS significantly inhibited the CCI-induced upregulation of Iba-1 and GFAP ( n = 5). (E–G) Focal rTSMS significantly inhibited CCI-induced upregulation of IL-1β, IL-6, and TNF-α in the spinal cord ( n = 5). (H, I) Focal rTSMS significantly inhibited the CCI-induced increase in the protein levels of p-p38 and p-STAT3 in the spinal cord ( n = 5). (J) Focal rTSMS significantly upregulated SOCS3 in the spinal cord ( n = 5). (K) Focal rTSMS could not upregulate <t>SOCS1</t> in the spinal cord ( n = 5). Data are expressed as mean ± SD. # P < 0.05, ### P < 0.001, #### P < 0.0001, vs. Sham group; * P < 0.05, ** P < 0.01, *** P < 0.001, vs . CCI group (one‐way analysis of variance followed by Tukey’s multiple comparisons tests). CCI: Chronic constrictive injury; GFAP: glial fibrillary acidic protein; Iba-1: ionized calcium binding adaptor molecule-1; IL: interleukin; rTSMS: repetitive trans-spinal magnetic stimulation; SOCS: suppressor of cytokine signaling; STAT3: transducer and activator of transcription 3; TNF-α: tumor necrosis factor-alpha.
Socs3 Mouse, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/socs3/129s7+b6+j+rag1tm1mom/pm41992230-170-21-28
Average 86 stars, based on 1 article reviews
socs3 mouse - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, STAT4, p‑STAT3, STAT3, SOCS1, SOCS3, and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Advanced Science

Article Title: Gut Microbiota‐Derived Indole‐3‐Acetaldehyde Contributes to the Disease‐Alleviating Effects of Kurarinone in Experimental Autoimmune Encephalomyelitis

doi: 10.1002/advs.78358

Figure Lengend Snippet: IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, STAT4, p‑STAT3, STAT3, SOCS1, SOCS3, and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: SDS loading buffer (Deeyeebio, 50053) was added to the cell lysis solution, and the proteins (30 μg/lane) were separated by SDS‐PAGE and transferred onto the PVDF membrane, and probed with primary antibodies against phospho‐JAK2 (Tyr1007/1008) (CST, 3771), JAK2 (CST, 3230), phospho‐STAT3 (Ser705) (CST, 9145), phospho‐STAT4 (Tyr693) (CST, 4134), STAT3 (Proteintech, 10253‐2‐ap), STAT4 (CST, 2653), SOCS1 (CST, 55313), SOCS3 (Proteintech, 14025‐1‐ap), and AhR (Proteintech, 67785‐1‐lg), followed by HRP‐conjugated secondary antibodies (Proteintech, SA00001‐1, SA00001‐2).

Techniques: Cell Differentiation, Analysis, In Silico, Binding Assay, Docking Assay, In Vitro, Knockdown, Immunofluorescence, Staining, Western Blot, Significance Assay

Graphical abstract. Schematic diagram illustrating the molecular mechanism by which KU ameliorates EAE through the gut microbiota‐IAAld‐AhR axis. KU reshapes gut microbiota composition in EAE mice, specifically increasing the abundance of Akkermansia muciniphila . A. muciniphila facilitates intestinal production of indole‐3‐acetaldehyde (IAAld) and the latter crosses the intestinal barrier to enter peripheral circulation and CNS, where IAAld activates AhR and promotes its nuclear translocation in CD4 + T cells. Once in the nucleus, activated AhR upregulates SOCS1 and SOCS3 expression and suppresses phosphorylation of JAK2 and its downstream targets, STAT4 and STAT3. This cascade restrains CD4 + T cell differentiation into Th1 and Th17 subsets, ultimately mitigating CNS inflammation and demyelination in EAE mice.

Journal: Advanced Science

Article Title: Gut Microbiota‐Derived Indole‐3‐Acetaldehyde Contributes to the Disease‐Alleviating Effects of Kurarinone in Experimental Autoimmune Encephalomyelitis

doi: 10.1002/advs.78358

Figure Lengend Snippet: Graphical abstract. Schematic diagram illustrating the molecular mechanism by which KU ameliorates EAE through the gut microbiota‐IAAld‐AhR axis. KU reshapes gut microbiota composition in EAE mice, specifically increasing the abundance of Akkermansia muciniphila . A. muciniphila facilitates intestinal production of indole‐3‐acetaldehyde (IAAld) and the latter crosses the intestinal barrier to enter peripheral circulation and CNS, where IAAld activates AhR and promotes its nuclear translocation in CD4 + T cells. Once in the nucleus, activated AhR upregulates SOCS1 and SOCS3 expression and suppresses phosphorylation of JAK2 and its downstream targets, STAT4 and STAT3. This cascade restrains CD4 + T cell differentiation into Th1 and Th17 subsets, ultimately mitigating CNS inflammation and demyelination in EAE mice.

Article Snippet: SDS loading buffer (Deeyeebio, 50053) was added to the cell lysis solution, and the proteins (30 μg/lane) were separated by SDS‐PAGE and transferred onto the PVDF membrane, and probed with primary antibodies against phospho‐JAK2 (Tyr1007/1008) (CST, 3771), JAK2 (CST, 3230), phospho‐STAT3 (Ser705) (CST, 9145), phospho‐STAT4 (Tyr693) (CST, 4134), STAT3 (Proteintech, 10253‐2‐ap), STAT4 (CST, 2653), SOCS1 (CST, 55313), SOCS3 (Proteintech, 14025‐1‐ap), and AhR (Proteintech, 67785‐1‐lg), followed by HRP‐conjugated secondary antibodies (Proteintech, SA00001‐1, SA00001‐2).

Techniques: Translocation Assay, Expressing, Phospho-proteomics, Cell Differentiation

Focal rTSMS significantly inhibits CCI-induced neuroinflammation and upregulates SOCS3 in the spinal cord in vivo . (A) Representative immunofluorescence images showing the inhibitory effects of focal rTSMS on CCI-induced activation of microglia and astrocytes in the dorsal horn ( n = 3). Dashed box indicates the region of interest in the dorsal horn of the spinal cord. Scale bars: 100 μm. (B) Representative image of western blotting. (C, D) Re-administration of rTSMS significantly inhibited the CCI-induced upregulation of Iba-1 and GFAP ( n = 5). (E–G) Focal rTSMS significantly inhibited CCI-induced upregulation of IL-1β, IL-6, and TNF-α in the spinal cord ( n = 5). (H, I) Focal rTSMS significantly inhibited the CCI-induced increase in the protein levels of p-p38 and p-STAT3 in the spinal cord ( n = 5). (J) Focal rTSMS significantly upregulated SOCS3 in the spinal cord ( n = 5). (K) Focal rTSMS could not upregulate SOCS1 in the spinal cord ( n = 5). Data are expressed as mean ± SD. # P < 0.05, ### P < 0.001, #### P < 0.0001, vs. Sham group; * P < 0.05, ** P < 0.01, *** P < 0.001, vs . CCI group (one‐way analysis of variance followed by Tukey’s multiple comparisons tests). CCI: Chronic constrictive injury; GFAP: glial fibrillary acidic protein; Iba-1: ionized calcium binding adaptor molecule-1; IL: interleukin; rTSMS: repetitive trans-spinal magnetic stimulation; SOCS: suppressor of cytokine signaling; STAT3: transducer and activator of transcription 3; TNF-α: tumor necrosis factor-alpha.

Journal: Neural Regeneration Research

Article Title: Trans-spinal magnetic stimulation upregulates microglial SOCS3 to attenuate neuroinflammation in chronic constriction injury–induced neuropathic pain

doi: 10.4103/NRR.NRR-D-24-00912

Figure Lengend Snippet: Focal rTSMS significantly inhibits CCI-induced neuroinflammation and upregulates SOCS3 in the spinal cord in vivo . (A) Representative immunofluorescence images showing the inhibitory effects of focal rTSMS on CCI-induced activation of microglia and astrocytes in the dorsal horn ( n = 3). Dashed box indicates the region of interest in the dorsal horn of the spinal cord. Scale bars: 100 μm. (B) Representative image of western blotting. (C, D) Re-administration of rTSMS significantly inhibited the CCI-induced upregulation of Iba-1 and GFAP ( n = 5). (E–G) Focal rTSMS significantly inhibited CCI-induced upregulation of IL-1β, IL-6, and TNF-α in the spinal cord ( n = 5). (H, I) Focal rTSMS significantly inhibited the CCI-induced increase in the protein levels of p-p38 and p-STAT3 in the spinal cord ( n = 5). (J) Focal rTSMS significantly upregulated SOCS3 in the spinal cord ( n = 5). (K) Focal rTSMS could not upregulate SOCS1 in the spinal cord ( n = 5). Data are expressed as mean ± SD. # P < 0.05, ### P < 0.001, #### P < 0.0001, vs. Sham group; * P < 0.05, ** P < 0.01, *** P < 0.001, vs . CCI group (one‐way analysis of variance followed by Tukey’s multiple comparisons tests). CCI: Chronic constrictive injury; GFAP: glial fibrillary acidic protein; Iba-1: ionized calcium binding adaptor molecule-1; IL: interleukin; rTSMS: repetitive trans-spinal magnetic stimulation; SOCS: suppressor of cytokine signaling; STAT3: transducer and activator of transcription 3; TNF-α: tumor necrosis factor-alpha.

Article Snippet: The primary antibodies used included β-actin (rabbit, 1:5000; Abclonal, Wuhan, China, Cat# AC026, RRID: AB_2768234), SOCS3 (rabbit, 1:1000; Abclonal, Cat# A0694, RRID: AB_2757345), SOCS1 (rabbit, 1:1000; Abclonal, Cat# A7754, RRID: AB_2772339), CaMKKβ (rabbit; Cell Signaling Technology, Danvers, MA, USA, Cat# 16810, RRID: AB_2798771), phospho-CaMKKβ(Ser511) (rabbit, 1:500; Cell Signaling Technology, Cat# 12818, RRID: AB_2798034), phosphorylated AMPK (Thr172) (p-AMPK; rabbit, 1:1000; Cell Signaling Technology, Cat# 2535S, RRID: AB_331250), AMPK (rabbit, 1:2000; Abcam, Cambridge, UK, Cat# ab32047, RRID: AB_722764), glial fibrillary acidic protein (GFAP; rabbit, 1:1000; Cell Signaling Technology, Cat# 12389S, RRID:AB_2631098), ionized calcium binding adaptor molecule-1 (Iba-1; goat, 1:1000; Abcam, Cat# ab48004, RRID: AB_870576), matrix metalloproteinase 9 (MMP-9; rabbit,1:1000; Proteintech, Rosemont, IL, USA, Cat# 10375-2-AP, RRID: AB_2919732), phospho-signal transducer and activator of transcription 3 (rabbit, 1:1000; Abclonal, Cat# AP0070, RRID: AB_2771569), signal transducer and activator of transcription 3 (STAT3; rabbit, 1:1000; Abclonal, Cat# A1192, RRID: AB_2861642), phospho-p38 mitogen-activated protein kinase (p-p38; rabbit, 1:1000; Cell Signaling Technology; Cat# 4511, RRID: AB_2139682), p38 mitogen-activated protein kinase (p38; rabbit, 1:1000; Cell Signaling Technology, Cat# 4511, RRID: AB_11178801), TNF-α (1:1000; Abclonal, Cat# A20851), IL-1β (1:1000; Abclonal, Cat# A16288), and IL-6 (rabbit, 1:1000; Abcam, Cat# ab6672, RRID: AB_2127460).

Techniques: In Vivo, Immunofluorescence, Activation Assay, Western Blot, Binding Assay